Literature DB >> 9400644

Brain cavernoma: a dynamic lesion.

J P Houtteville1.   

Abstract

BACKGROUND: Although the prevalence of brain cavernomas is high (0.50%), for unknown reasons, only a few of them display aggressive clinical behavior.
METHODS: From a personal series of 65 operated and histopathologically verified cavernomas, we have conducted a long-term study, both retrospectively and prospectively, of the main features that cause some cavernomas to be dynamic lesions.
RESULTS: Hemorrhage is the most common phenomenon. Extralesional bleeding due to the rupture of peripheral caverns is most often observed. These are never as immediately devastating as hemorrhages originating from a high-flow, high-pressure AVM. Extralesional hemorrhages tend toward spontaneous resorption, but the risk of recurrence exists and may lead to permanent disability or death (especially when the lesion is located in the brain stem). Intralesional bleeding caused by rupture of contiguous caverns is less frequently observed. This may lead to the formation of large cysts. Calcifications are mostly observed in patients presenting with chronic epilepsy. The bleeding risk of calcified cavernomas is low, but it can exist and should be taken into account in the surgical decision making. The growth of the cavernomatous matrix was obvious in three large cavernomas (two with calcification). No bleeding was found inside the lesions, suggesting a pure "intrinsic" growth. The role of pathologic angiogenic factors is highly probable in these cases. "De novo" appearing lesions were observed in five cases (four belonging to familial forms) on the magnetic resonance imaging survey of operated patients. Perilesional atrophy was observed in three cases (two operated) in patients with a long-lasting evolution. It suggests that the brain metabolism can be disturbed by slow, chronic effusion of blood around the cavernoma.
CONCLUSIONS: The dynamism of cavernomas is determined by extrinsic factors, mainly hemorrhage (with its own consequences); and by intrinsic factors: the pseudotumoral growth of the cavernous matrix. Therefore, when they are symptomatic, cavernomas should be totally removed.

Entities:  

Mesh:

Year:  1997        PMID: 9400644     DOI: 10.1016/s0090-3019(96)00551-4

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  16 in total

1.  [Cavernomas of the central nervous system : Observational study of 111 patients].

Authors:  C Mayer; U M Mauer; G Bluhm; R Mathieu; C Hackenbroch; S Mayer
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

2.  Giant cavernous malformation : a case report and review of the literature.

Authors:  Dong Wuk Son; Sang Weon Lee; Chang Hwa Choi
Journal:  J Korean Neurosurg Soc       Date:  2008-04-20

3.  Surgical management of symptomatic brain stem cavernoma in a developing country: technical difficulties and outcome.

Authors:  Ahmed Farhoud; Hisham Aboul-Enein
Journal:  Neurosurg Rev       Date:  2016-04-06       Impact factor: 3.042

Review 4.  Hyper-vascular giant cavernous malformation in a child: a case report and review.

Authors:  Koji Hirata; Satoshi Ihara; Masayuki Sato; Yuji Matsumaru; Tetsuya Yamamoto
Journal:  Childs Nerv Syst       Date:  2016-09-01       Impact factor: 1.475

5.  Multiple de novo vascular malformations in relation to diffuse venous occlusive disease: a case report.

Authors:  H A Desal; S K Lee; B S Kim; S Raoul; M Tymianski; K G TerBrugge
Journal:  Neuroradiology       Date:  2005-01-15       Impact factor: 2.804

6.  Giant cavernous hemangiomas: report of three cases.

Authors:  E J van Lindert; T C Tan; J A Grotenhuis; P Wesseling
Journal:  Neurosurg Rev       Date:  2006-09-19       Impact factor: 3.042

7.  MR imaging features that distinguish spinal cavernous angioma from hemorrhagic ependymoma and serial MRI changes in cavernous angioma.

Authors:  Inhwan Jeon; Woo Sang Jung; Sang Hyun Suh; Tae-Sub Chung; Yong-Eun Cho; Sung Jun Ahn
Journal:  J Neurooncol       Date:  2016-08-16       Impact factor: 4.130

Review 8.  A peri-trigonal giant tumefactive cavernous malformation: case report and review of literature.

Authors:  Sumit Thakar; Sunil V Furtado; Nandita Ghosal; A S Hegde
Journal:  Childs Nerv Syst       Date:  2010-07-28       Impact factor: 1.475

9.  Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients.

Authors:  Wuttipong Tirakotai; Sandra Fremann; Niels Soerensen; Wolfgang Roggendorf; Adrian M Siegel; Hans Dieter Mennel; Yuan Zhu; Helmut Bertalanffy; Ulrich Sure
Journal:  Childs Nerv Syst       Date:  2006-02-18       Impact factor: 1.475

10.  Multiple intracranial cavernomas with focal amyloid deposition - diagnostic pitfalls.

Authors:  T Velnar; G Bunc; D Flisar; D Kulaš; A Woehrer; H Budka; M Popoviä
Journal:  Clin Neuropathol       Date:  2011 Nov-Dec       Impact factor: 1.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.